| Date | Time | Source | Headline | Symbol | Company |
| 08/25/2023 | 5:02PM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:JNJ | Johnson and Johnson |
| 08/25/2023 | 4:53PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 08/25/2023 | 4:07PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 08/25/2023 | 4:07PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 08/25/2023 | 4:07PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 08/25/2023 | 4:07PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 08/25/2023 | 4:07PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 08/24/2023 | 7:12AM | IH Market News | Thursday’s Wall Street Highlights: Boeing, Nvidia, Guess, J&J, GM, and more | NYSE:JNJ | Johnson and Johnson |
| 08/23/2023 | 7:18AM | Dow Jones News | J&J Accepts 191 Million Shares in Exchange for 1.53 Billion Kenvue Shares, Finalizing Separation | NYSE:JNJ | Johnson and Johnson |
| 08/23/2023 | 7:04AM | Edgar (US Regulatory) | Form SC TO-I/A - Tender offer statement by Issuer: [Amend] | NYSE:JNJ | Johnson and Johnson |
| 08/23/2023 | 6:37AM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 08/23/2023 | 6:20AM | Business Wire | Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc. | NYSE:JNJ | Johnson and Johnson |
| 08/22/2023 | 10:24AM | Business Wire | Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference | NYSE:JNJ | Johnson and Johnson |
| 08/22/2023 | 7:19AM | IH Market News | Tuesday’s Wall Street Highlights: Baidu, Lowe’s, American Airlines, S&P Global, and more | NYSE:JNJ | Johnson and Johnson |
| 08/21/2023 | 6:01PM | PR Newswire (US) | Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600 | NYSE:JNJ | Johnson and Johnson |
| 08/21/2023 | 8:19AM | Dow Jones News | Titan Medical Signs Licensing Agreement with Auris Health | NYSE:JNJ | Johnson and Johnson |
| 08/21/2023 | 7:51AM | Dow Jones News | J&J's Offer for Kenvue Shares Oversubscribed | NYSE:JNJ | Johnson and Johnson |
| 08/21/2023 | 6:52AM | Edgar (US Regulatory) | Form SC TO-I/A - Tender offer statement by Issuer: [Amend] | NYSE:JNJ | Johnson and Johnson |
| 08/21/2023 | 6:38AM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 08/21/2023 | 6:20AM | Business Wire | Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer | NYSE:JNJ | Johnson and Johnson |
| 08/18/2023 | 5:11PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 08/17/2023 | 4:53PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 08/17/2023 | 6:23AM | Edgar (US Regulatory) | Form SC TO-I/A - Tender offer statement by Issuer: [Amend] | NYSE:JNJ | Johnson and Johnson |
| 08/16/2023 | 9:22PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 08/16/2023 | 6:52PM | Business Wire | Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc. | NYSE:JNJ | Johnson and Johnson |
| 08/16/2023 | 4:43PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 08/15/2023 | 4:43PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 08/14/2023 | 4:44PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 08/11/2023 | 5:38PM | Dow Jones News | Janssen Pharmaceutical: Akeega Gets FDA Approval to Treat Prostate Cancer Patients | NYSE:JNJ | Johnson and Johnson |
| 08/11/2023 | 4:51PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |